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Abstract 
The aim of this review is to highlight novel findings in 2019 in the area of neurovascular disease. Experimental 
studies have provided insight into disease development, molecular determinants of pathology, and putative 
novel therapeutic targets. Studies in genetic experimental models as well as monogenic forms of human cere-
brovascular diseases identified pathogenic molecules that may also be relevant to sporadic cases. There have 
been advances in understanding the development of cerebral cavernous angiomas and arteriovenous malfor-
mations, and putative curative treatments have been suggested from experimental models. Key pathogenic 
pathways involved in vessel calcification and stiffness have also been identified. At the cellular level, studies 
showed that proper function of endothelial and mural cells, particularly pericytes, is crucial to ensure full endo-
thelial differentiation and blood-brain barrier integrity. Moreover, recent discoveries support the existence of a 
homeostatic crosstalk between vascular cells and other neural cells, including neurons. Cerebrovascular diseas-
es are strongly associated with inflammation. Beyond pathogenic roles of specific components of the inflam-
matory response, new discoveries showed interesting interactions between inflammatory molecules and regu-
lators of vascular function. Clinical investigation on cerebrovascular diseases has progressed by combining ad-
vanced imaging and genome-wide association studies. Finally, vascular cognitive impairment and dementia are 
receiving increasing attention. Recent findings suggest that high-salt intake may cause cerebrovascular dys-
function and cognitive impairment independent of hypoperfusion and hypertension. These and other recent 
reports will surely inspire further research in the field of cerebrovascular disease that will hopefully contribute 
to improved prevention and treatment. 
 
Abbreviations 
ApoE, Apolipoprotein E; AVM, Arteriovenous malfor-
mations; BBB, Blood-brain barrier; CAA, cerebral amy-
loid angiopathy; CADASIL, Cerebral autosomal dominant 
arteriopathy with subcortical infarcts and leukoencepha-
lopathy; CARASIL, Cerebral autosomal recessive arteri-
opathy with subcortical infarcts and leukoencephalopa-
thy; CBF, Cerebral blood flow; CCM, Cerebral cavernous 
angiomas; Cdk5, Cyclin-dependent kinase 5; DTI, Diffu-
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sion tensor imaging; EndMT, Endothelial-to-
mesenchymal transition; GOM, Granular osmiophilic 
material; iPSCs, induced pluripotent stem cells; Pdgfb, 
Platelet-derived growth factor subunit β; PFBC, primary 
familial brain calcification, Fahr’s disease; SAH, Sub-
arachnoid hemorrhage; SMCs, Smooth muscle cells; 
TIMP3, Tissue inhibitor of metalloproteinase 3; TGFβ, 
Transforming growth factor-β 
Introduction 
In the next pages I will discuss a few topics in the 
field of cerebrovascular disease that I believe have made 
advances in 2019 supported by excellent studies cover-
ing genetic and sporadic forms of the diseases in hu-
mans and experimental animals. 
1. Cavernous angiomas originate from 
clonal expansion of mutated endothe-
lial cells 
There have been recent advances in understanding 
the development of cerebral cavernous angiomas (CCM). 
New results suggest that small angiomas may derive 
from a clonal expansion of mutant endothelial cells that 
undergo endothelial-to-mesenchymal transition and 
express stem-cell like features (Fig. 1). CCM are vascular 
lesions composed of clusters of capillary-venous blood 
vessels with thin walls and impaired endothelial tight 
junctions that usually contain stagnant blood. These 
abnormal vessels may rupture causing intracranial hem-
orrhage (Fig. 1) or small subclinical bleeds, which may 
lead to seizures. Most cases of CCM are spontaneous but 
20% of cases may be attributed to autosomal dominant 
inheritance. The disease is caused by sporadic or inherit-
ed mutations in one of the following three genes: CCM1 
(KRIT1), CCM2 (MGC4607), or CCM3 (PDCD10). In the 
affected vessels, endothelial cells suffer endothelial-to-
mesenchymal transition (EndMT), express stem cell 
markers, and undergo loss of typical endothelial cell 
properties, with increased cell migration, reduced ad-
herence, and increased blood-brain barrier (BBB) per-
meability. In familial cases, the vascular lesions are dis-
crete although the above genetic mutations affect all 
cells. Furthermore, heterozygous mice do not develop 
the disease. The prevalent explanation is the two-hit 
hypothesis. Endothelial cells carrying a germline muta-
tion in one of the CCM genes need to suffer a second, 
likely a somatic, mutation that will trigger the pathology. 
Malinverno et al. (2019) showed that only a few 
 
Figure 1. Cavernomas. Schematic representation of cavernoma generation from vessels with mutated CCM genes (see text section 1). 
According to Malinverno et al., (2019), the process involves endothelial-to-mesenchymal transition (EndMT) and clonal expansion. 
Susceptibility weighted imaging shows a cavernoma with hemorrhage in the right occipital lobe (arrow). The MRI image was obtained in 
the Comprehensive Stroke Center of Hospital Clinic of Barcelona. 
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endothelial cells bearing a Ccm3-/- mutation, undergoing 
EndMT, and expressing progenitor markers, are needed 
to generate cavernomas because the affected cells un-
dergo clonal expansion. Demonstration of clonal expan-
sion was carried out using an elegant strategy by cross-
ing the ‘R26R-Confetti’ mouse, a multicolor reporter 
mouse model, first with Cdh5(PAC)-CreERT2 mice for an 
endothelial specific expression of cre, and then with 
Ccm3fl/fl mice. Endothelial deletion of Ccm3 was accom-
panied by color-based clonal lineage tracing. The majori-
ty of small vascular lesions were composed of cells of 
the same color suggesting a clonal origin from prolifera-
tion of the affected endothelial cells. This study followed 
two previous studies (Detter et al., 2018; Manavski et 
al., 2018) where clonal expansion of mutant endothelial 
cell in CCM EndMT was also demonstrated using a re-
porter Confetti strategy. In contrast to the clonal origin 
of small lesions, large cavernomas are mosaics contain-
ing clonally dominant mutant cells and wild type endo-
thelial cells suggesting recruitment of neighboring wild 
type cells to the cavernous lesion. Those wild type endo-
thelial cells also overexpressed EndMT markers. Trans-
plantation of Ccm3-/- cells into the brain of wild type 
mice generated abnormal vessels and recruited endo-
thelial cells from the host (Malinverno et al., 2019). By 
means of several in vitro studies, these authors demon-
strated that wild type endothelial cells acquire features 
of EndMT after contacting Ccm3-/- cells. Furthermore, by 
using genetic mouse models, Malinverno et al. deleted 
Ccm3 in endothelial progenitors. They hypothesized that 
the early steps of cavernoma formation are due to clonal 
expansion of resident endothelial progenitors. In this 
way they provided evidence supporting the view that 
endothelial progenitors suffering Ccm3 mutation trigger 
cavernoma formation. Hopefully these new discoveries 
will provide novel avenues to prevent or attenuate CCM. 
2. Cerebral arteriovenous malfor-
mations: From origin to treatment 
Failure to achieve full endothelial cell differentia-
tion could underlie the pathology of arteriovenous mal-
formations (AVMs) where recent studies identified β-
adrenergic antagonists as putative curative treatments. 
AVMs involve the formation of arteriovenous shunts 
amongst other vascular abnormalities including vessel 
calcifications, and the presence of surrounding macro-
phages and gliosis. This condition impairs oxygen deliv-
ery to the parenchyma and predisposes to vessel rup-
ture and hemorrhage. Alterations in endothelial cell 
EndMT are associated with this pathology. Yao et al. 
(2019) recently investigated the presence of EndMT 
markers in the endothelium of human AVMs. Through 
complementary strategies they identified the expression 
of the stem cell marker Sry-box 2 (Sox2) and the mesen-
chymal marker N-cadherin in lesional endothelial cells, 
together with a reduction in the expression of typical 
endothelial markers. The authors also investigated a 
mouse model of AVMs, the matrix gla protein null 
(Mgp-/-) mouse, which develops arterial calcifications, 
enlarged vessels, and arterial-venous shunts. Cerebral 
endothelial cells of these mice also overexpressed 
Sox2.They limited Sox2 expression in endothelial cells by 
generating heterozygous Cdh5-cre/Sox2fl/wt mice with 
endothelial deletion of Sox2 in heterozygosis. These 
mice were bred with Mgp-/- mice, which no longer over-
expressed Sox2 and, importantly, the pathological vascu-
lar features of AVMs were strongly attenuated. Moreo-
ver, reduction of Sox2 abolished the expression of 
EndMT markers. Chip-Seq analysis showed alterations in 
histone methylation affecting the expression of several 
genes that participate in stem cell pathways and epithe-
lial-mesenchymal signaling. The analysis identified over-
expression of the gene JMJD5 in Mgp-/- cerebral endo-
thelial cells as a downstream target of Sox2. Then, a 
human brain microvascular endothelial cell line depleted 
of MGP was generated using CRISP/Cas9 technology. 
This line showed higher expression of N-cadherin than 
wild type cells, suggesting EndMT. In addition, these 
cells overexpressed Sox2 and JMJD5. Sox2 depletion 
reduced JMJD5 expression. Further experiments sug-
gested that Sox2 also interacts with JMJD5 to regulate 
EndMT. To identify drugs that could prevent AVMs by 
inhibiting Sox2, a high-throughput robotic model was 
generated using a cell line that allowed screening of 
more than 3,000 products. The system identified a drug 
called pronethanol, which was shown to effectively re-
duce Sox2 expression. Furthermore, treatment of Mgp-/- 
mice with pronethanol for 14 days improved the cere-
bral vasculature in AVM. Interestingly, pronethanol is a 
non-selective beta-blocker with the drawback of causing 
neurological side effects in humans and carcinogenesis 
in mice. A number of ß-adrenergic drugs were subse-
quently tested. The results showed that ß-adrenergic 
antagonists decreased Sox2 and EndMT, and improved 
lumen formation. This study is a good example of the 
way mechanistic studies in human tissue, human cells, 
and animal models lead to the discovery of potential 
drugs to improve the disease. Previous studies in Mgp-/- 
mice had shown the contribution of EndMT and the 
emergence of multipotent cells to the process of ossifi-
cation and vascular calcification (e.g. Yao et al., 2013). 
Like in the case of CCMs, failure of brain endothelial cells 
to acquire or maintain their differentiation state gener-
ates aberrant vessels and vascular diseases.
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3. Arterial stiffness and calcifications: 
Molecular insights and consequences 
Vessel calcification and arterial stiffness are com-
mon in the aged population. Arterial stiffness is caused 
by structural alterations reducing arterial wall distensi-
bility and the arterial capacity to buffer pulsatile cardiac 
ejection. This condition is epidemiologically associated 
with hypertension and cognitive decline. Arterial calcifi-
cation is an important cause of arterial stiffness but the 
contribution of calcifications to cognitive decline over 
other associated features is unclear. Muhire et al. (2019) 
showed in experimental animals that carotid calcifica-
tion attenuated resting cerebral blood flow (CBF), im-
paired cerebral autoregulation, and induced cognitive 
deficits. The study used a mouse model of arterial stiff-
ness induced by direct application of CaCl2 on the carotid 
artery. The model is characterized by reduced arterial 
compliance and distensibility, increased thickness of the 
intima-media, and fragmentation of the internal elastic 
lamina, without increased systolic blood pressure. Carot-
id stiffness increased BBB permeability in the hippocam-
pus where the number of collagen IV+ vessels decreased, 
suggesting a pathogenic role of these calcifications. 
Regarding the molecular mechanisms underlying vessel 
calcifications in brain arteries, a recent study pointed to 
the involvement of osteopontin and TGFβ signaling in 
the pathogenesis of calcifications (Grand Moursel et al., 
2019). Osteopontin is an extracellular glycoprotein with 
diverse features. It is cleaved by thrombin and cleaved 
forms can bind to several integrin receptors expressed 
by immune cells. Given that vascular calcifications are 
detected in the cerebral cortex in severe forms of cere-
bral amyloid angiopathy (CAA), the study investigated 
molecular modulators of arterial calcifications in post-
mortem tissue of eight patients with hereditary cerebral 
hemorrhage with amyloidosis-Dutch type (HCHWA-D or 
D-CAA). Calcified vessel walls showed overexpression of 
medial and abluminal collagen type I. They also overex-
pressed osteopontin and TGFβ signaling factor phospho-
SMAD2/3, and accumulation of these factors preceded 
overt vessel calcifications. The study found significant 
positive correlations between the level of osteopontin 
and phospho-SMAD2/3 and disease severity and sug-
gested the involvement of these molecules in cerebral 
artery calcifications in CAA. More severe brain vessel 
calcifications are found in certain rare genetic diseases. 
Primary familial brain calcification (PFBC) is a heritable 
disease also termed Fahr’s disease. It is a rare form of 
brain calcification affecting vessels of the basal ganglia 
and often manifests with neuropsychiatric symptoms. 
Zarb et al. (2019) used a mouse model with mutations in 
Platelet-derived growth factor subunit-β (Pdgfb) gene 
causing reduced endothelial expression of this factor, 
resulting in vascular calcifications associated with peri-
cyte loss and BBB alterations. Interestingly, the mouse 
model recapitulated several behavioral alterations over-
lapping with PFBC, including sensorimotor deficits, hy-
peractivity, anxiety and impaired working memory. Cells 
surrounding brain vessel calcifications expressed osteo-
blast, osteoclast, and osteocyte markers. The extracellu-
lar matrix contained bone matrix proteins. Importantly, 
blood vessel ossification was also demonstrated in brain 
tissue from primary familial brain calcification patients. 
Another consequence of vessel calcifications was activa-
tion of microglial and astroglial cells. Given the reported 
astrogliosis in PFBC patients, astrocytes were investigat-
ed in the mouse model. Notably, GFAP+ astrocytes sur-
rounding calcifications expressed oxidative stress and 
inflammatory neurotoxic markers, such as complement 
component 3 (C3) and lipocalin 2. 
4. Inflammation/innate immunity: 
Role of complement activation 
Inflammation is present in most brain diseases af-
fecting the elderly, including cerebrovascular disease. 
Recently, activation of the complement cascade was 
shown to play a pathogenic role in subarachnoid hemor-
rhage. Moreover, interaction between initiator comple-
ment component C1q and ApoE was reported. Comple-
ment activation has been reported in cerebrovascular 
diseases and several lines of evidence strongly support 
the involvement of complement in secondary tissue 
injury following acute stroke. C3 is amongst key bi-
omarkers associated with increased risk of major disabil-
ity, mortality and vascular events following ischemic 
stroke (Zhong et al., 2019). Complement activation is 
also associated with poor functional outcome following 
aneurysmal subarachnoid hemorrhage (SAH). A recent 
study showed that complement components C1q, 
C3/C3b/iC3B were more abundant in the brain of SAH 
patients than controls (van Dijk et al., 2019). A single 
nucleotide polymorphism in C5 correlated with poor 
outcome in SAH patients, which showed increased levels 
of C5a in CSF and plasma. In a mouse model of SAH, 
blocking C5 activation, using mice deficient in C5a or 
after administration of C5a blocking antibodies, reduced 
microglial activation and neural cell death. Interestingly, 
a recent study discovered molecular links between com-
plement and apolipoprotein-E (ApoE). ApoE is a factor 
associated with Alzheimer’s disease, cerebrovascular 
diseases, and atherosclerosis (Yin et al., 2019). Human 
ApoE has four isoforms ApoE, ApoE2, ApoE3, and ApoE4. 
The ApoE4 allele is an important risk factor for late onset 
Alzheimer’s disease, whereas several studies indicate 
that altered ApoE2 could be associated with white mat-
ter hyperintensities in small vessel diseases. Yin et al. 
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(2019) showed absence of ApoE-mediated activation of 
the classical complement cascade in the choroid plexus. 
Lipid deposits were noticed in choroid plexus of aged 
ApoE-/- mice regardless of whether they were fed a high 
fat diet or normal chow. Knockin mice expressing the 
human form of ApoE4 (ApoE4-KI) also showed lipid de-
posits in the choroid plexus but only when fed a high fat 
diet. In contrast, ApoE3-KI mice did not develop those 
lipid deposits irrespective of diet regimen. Lipid accumu-
lation was paralleled by leukocyte accumulation in the 
choroid plexus and CSF. Using laser-capture microdissec-
tion of choroid plexus followed by differential gene ex-
pression profiling, an interferon signature was detected 
in ApoE4-KI mice. Additionally, upregulation of comple-
ment genes was detected in ApoE-/- mice. Accordingly, 
the choroid plexus of ApoE-/- mice showed accumulation 
of immunoglobulins, and complement proteins C1q, C3, 
C4, as well as C5 and anaphylatoxin C3a. Through vari-
ous in vitro strategies, the study demonstrated that 
ApoE inhibits the classical pathway of complement acti-
vation through Ca2+-dependent high affinity binding to 
the activated form of C1q, which was elicited by all ApoE 
isoforms. Notably, the formation of lipid droplets in the 
choroid plexus was found in human brains with various 
degrees of Alzheimer’s disease pathology, and higher 
lipid droplet numbers were found in patients with de-
mentia. Lipid deposits were associated with C1q-ApoE 
complex. Furthermore, C1q and ApoE colocalized in 
atherosclerotic plaques. Overall, the study suggests that 
ApoE may prevent complement activation. Altered inhib-
itory effects of ApoE on complement due to allelic alter-
ations is proposed as a pathogenic mechanism in Alz-
heimer’s disease and atherosclerosis. Further studies will 
hopefully elucidate the role of this new molecular inter-
action between ApoE and complement in cerebrovascu-
lar and neurodegenerative diseases. 
5. Cerebral amyloid angiopathy: Mi-
crobleeds, microinfarcts and white 
matter hyperintensities 
Progress has been made in understanding the neu-
ropathology of CAA as well as the neuropathological 
correlates of MRI alterations in this condition. CAA can 
lead to symptomatic lobar intracerebral hemorrhage. 
MRI of CAA patients may show microbleeds, microin-
farcts, and white matter hyperintensities (Reijmer et al., 
2015). Van Veluw et al. (2019a) reported that mi-
crobleeds and microinfarcts represent different micro-
vascular alterations in CAA. The vessels showing mi-
crobleeds had accumulation of amyloid β (Aβ) and fi-
brin/fibrinogen upstream and downstream of the mi-
crobleed, but not in the microbleed region devoid of 
smooth muscle cells (SMCs). Likewise, SMCs were miss-
ing in the regions of microinfarcts, but in this case Aβ 
was present in the injured core. The study suggested 
that removal of Aβ in vessels that have lost SMCs might 
increase the risk of bleeding, which, if confirmed, might 
potentially have future therapeutic implications. Using 
high resolution MRI in post-mortem brain tissue with 
correlative histopathological analyses, Van Veluw et al 
(2019b) provided relevant information on the neuropa-
thological correlates of neuroimaging alterations. Diffu-
sion tensor imaging (DTI) is the MRI modality best suited 
to study white matter fiber track orientation and physi-
cal features that can assess microstructural integrity of 
the brain tissue. The post-mortem brain of CAA patients 
was fixed with 10% formalin for at least 3 weeks. One 
brain hemisphere was scanned in a 3T MRI scanner for 
14 hours. Image analysis included fiber tractography, 
and 3-mm thick regions of interest were highlighted in 
parts of the tracts later taken for histology. Formalin 
fixation alters the MRI diffusion properties, but fraction-
al anisotropy measured in vivo was linearly related with 
fractional anisotropy acquired ex vivo in the same brains. 
The tissue was embedded in paraffin and 6-µm thick 
sections were obtained for histological analyses. The 
studies found reduced fractional anisotropy in CAA pa-
tients compared to controls. In multivariate analysis, 
fractional anisotropy data was independently associated 
with tissue rarefaction as assessed with Luxol fast blue & 
hematoxylin, lower myelin density as assessed with 
immunohistochemistry against myelin basic protein, and 
decreased axonal density determined by immunohisto-
chemistry against neurofilament (NF200). Another DTI 
parameter, mean diffusivity, was increased in CCA pa-
tients and was independently associated with myelin 
density (Van Veluw et al., 2019b). Moreover, increased 
mean diffusivity in the frontal white matter was associ-
ated with CAA severity in the frontal cortex. In contrast, 
the DTI changes were not related to markers of gliosis or 
with oligodendrocyte counts. Investigations on the neu-
ropathological correlates of imaging alterations are im-
portant because MRI is widely available and can be used 
to follow the progression of disease. 
6. Novel mechanisms underlying CA-
DASIL vasculopathy 
Cerebral autosomal dominant arteriopathy with 
subcortical infarcts and leukoencephalopathy (CADASIL) 
is the most common hereditary monogenic form of cer-
ebral small vessel disease. CADASIL leads to early onset 
hemorrhagic or ischemic stroke and vascular dementia. 
Recent findings in CADASIL unraveled novel molecular 
targets by describing attenuated vascular dysfunction 
due to inhibitors of endoplasmic reticulum stress and 
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modulators of the cytoskeleton, or due to vascular endo-
thelial growth factor supplementation. CADASIL pathol-
ogy develops due to mutations in the Notch3 gene which 
result in dysfunction of vascular SMCs. Notch3 is in-
volved in vasculogenesis and is mainly expressed in 
SMCs in adults. However, no specific therapies have 
been developed so far, possibly because there are many 
aspects of Notch3 function that remain currently un-
known. A recent study (Neves et al. 2019) identified 
molecular targets involved in vascular dysfunction in 
CADASIL. Notably, the study replicates in a CADASIL 
mouse model, the TgNotch3R169C mouse, the same 
findings as in human CADASIL. Samples were obtained 
from peripheral biopsies of CADASIL patients. Molecular 
alterations were identified in peripheral arteries despite 
the fact that CADASIL pathology manifests principally in 
cerebral vessels. Peripheral vessels of CADASIL patients 
showed impaired vascular reactivity and altered vascular 
structure with features suggesting reduced stiffness. 
Alterations in SMC proliferation, apoptosis, and cyto-
skeletal disorganization was also noted. Vascular SMCs 
of CADASIL patients showed increased NOTCH3 signal-
ing, NOTCH3 ectodomain (Notch3ECD) accumulation, and 
expression of NOTCH3 target genes relative to control 
patients. The study also showed Nox5 upregulation 
linked to an exaggerated endoplasmic reticulum stress 
response and aberrant cytoskeleton-associated protein 
phosphorylation in CADASIL. Moreover, the study re-
ports that inhibitors of Notch3, Nox5, ER stress, and 
RhoA/Rho kinase attenuate vascular dysfunction. This 
finding identifies putative pharmacologic therapeutic 
targets. Vascular SMCs in CADASIL are surrounded by 
deposits of granular osmiophilic material (GOM). How-
ever, the mechanisms underlying GOM formation and 
their contribution to disease progression are unknown. 
A recent study investigated the course of GOM deposit 
evolution in humanized TgNotch3Arg182Cys mice 
(Gravesteijn et al., 2019) and in human CADASIL tissue. 
GOM deposits are electron dense and are composed of 
Notch3ECD and extracellular matrix proteins, notably 
tissue inhibitor of metalloproteinase 3 (TIMP3) and clus-
terin, that accumulate in the basement membrane of 
vascular SMCs and pericytes. The study proposes a five-
stage GOM classification system based on size, mor-
phology, and electron density of the GOM deposits in 
order to generate a more systematic, uniform, and unbi-
ased way of analyzing GOM accumulations. It appears 
that new GOM deposits are continuously generated. 
However, GOM in TgNotch3Arg182Cys mice did not reach 
the end-stage of GOM accumulation as in human dis-
ease. A limitation of the study is that unlike other CA-
DASIL mouse models, the TgNotch3Arg182Cys mouse lacks 
histologic vascular pathology and functional deficits. The 
authors suggest that this phenomenon could be at-
tributed to absence of end-stage GOM accumulation in 
these mice. Beyond mouse models, the cellular CADASIL 
pathology has been investigated in patient-specific vas-
cular mural cells generated from induced pluripotent 
stem cells (iPSCs) obtained from skin biopsies of CADASIL 
patients (Kelleher et al., 2019). This study showed altera-
tions in endothelial capillary structures caused by the 
aberrant NOTCH3 expression in mural cells, and correc-
tive effects of vascular endothelial growth factor sup-
plementation. These novel advances are steps toward 
the identification of novel therapeutic targets in this 
monogenic form of small vessel disease. 
7. Genetic variants in small vessel dis-
ease and molecular target discovery 
In addition to studies examining monogenic forms 
of small vessel disease, there are efforts to study genetic 
variation in large cohorts of patients to identify genes 
involved in sporadic small vessel disease. Genome-wide 
association studies correlating variants with MRI fea-
tures of sporadic small vessel disease may lead to the 
identification of new putative pharmacologic targets. 
Small vessel disease is often diagnosed on MRI, with 
characteristic findings including white matter hyperin-
tensities and signs of lacunar infarcts (Fig. 2). Some re-
cent studies investigated the relationship between ge-
netics and white matter hyperintensities in small vessel 
disease. Traylor et al (2019) carried out a genome-wide 
association meta-analysis of white matter hyperintensity 
volumes in 11,226 subjects, including 2,797 stroke pa-
tients. The study identified a locus at genome-wide sig-
nificance in an intron of Pleckstrin Homology and 
RhoGEF Domain-Containing Family G Member 1 gene 
(PLEKHG1) associated with white matter hyperintensi-
ties. The association was validated in an independent 
cohort where this polymorphism was related with is-
chemic strokes. The strongest association was found 
with small vessel stroke. PLEKHG1 plays a role in vascu-
lar endothelial cell reorientation in response to mechan-
ical stress. Therefore, the polymorphism in this gene 
could generate some form of vascular alteration leading 
to the development of white matter hyperintensities. 
This study also validated 2 previously identified genes 
EFEMP1 and TRIM47/TRIM65. According to current 
knowledge, EFEMP1 encodes the Fibulin3 protein, which 
is an extracellular matrix glycoprotein that inhibits 
TIMP3. TIMP3 contributes to cerebrovascular dysfunc-
tion in CADASIL through accumulation in the vascular 
extracellular matrix. Therefore, there seems to be some 
concordance between genetic alterations in sporadic 
small vessel disease and the monogenic form of CA-
DASIL. Based on the concept that polymorphisms in 
genes involved in monogenic forms of small vessel dis-
ease may have some contribution in the sporadic form 
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Figure 2. Lacunar infarcts typical of small vessel disease. A) Human brain tissue showing a lacunar infarct (arrow) in the centrum semi-
ovale. Image obtained by Dr. Iban Aldecoa, Neurological Tissue Bank of the Biobank of Hospital Clínic - IDIBAPS - University of Barcelona. 
B) MRI showing a thalamic lacunar infarct (arrow) and C) corresponding CT-perfusion time-to-drain (TTD) image obtained in the acute 
phase showing a delay in blood flow in the lacunar infarction (arrow). Images in B and C were obtained in the Comprehensive Stroke 
Center of Hospital Clinic of Barcelona. 
 
of the disease, Mishra et al. (2019) carried out the first 
whole exome sequencing study on MRI white matter 
hyperintensities in small vessel disease. This work used a 
composite extreme phenotype study focused on candi-
date genes with mutations causing Mendelian heritable 
forms of small vessel disease, i.e. NOTCH3, HTRA1, 
COL4A1, COL4A2 and TREX1. The study identified signifi-
cant associations of gene variants in HTRA1 and NOTCH3 
with the development of white matter hyperintensities. 
Overall the study demonstrates shared mechanisms 
between monogenic forms and multifactorial forms of 
small vessel disease. The study suggested that the risk 
HTRA1 allele reduced HTRA1 expression. Mutations in 
HTRA1 are associated with cerebral autosomal recessive 
arteriopathy with subcortical infarcts and leukoencepha-
lopathy, CARASIL, a condition inherited in an autosomal 
recessive pattern. HTRA1 is a serine-protease involved in 
cleaving extracellular matrix proteins, including Fibulin3, 
and regulating important signaling pathways such as the 
insulin growth factor and TGFß pathway, which suffers 
an inhibitory effect. Notably, HTRA1 is differentially 
expressed in astrocytes (Chen et al., 2018) suggesting 
that dysfunction of this pathway may alter astrocyte 
function leading to compromised integrity of the neuro-
vascular unit and the BBB. Hopefully additional studies 
using iPSC from patients and genetically modified animal 
models further investigating molecular targets identified 
in prior genetic studies will lead to the discovery of 
treatments to prevent and attenuate the progression of 
small vessel disease. 
8. Cerebral hypoperfusion and vascu-
lar cognitive impairment: Risks of 
high-salt diet 
Chronic cerebral hypoperfusion has been associat-
ed with diffuse white matter damage and cognitive im-
pairment of vascular origin. Vascular pathology is also 
frequently observed in neurodegenerative dementias. 
Hase et al. (2019) investigated the histopathologic fea-
tures of white matter capillaries by studying approxi-
mately 0.7 million capillary profiles from the frontal lobe 
white matter of 153 subjects with different dementia 
types including Alzheimer’s disease, dementia with Lewy 
bodies, dementia in Parkinson’s disease, vascular de-
mentia, mixed dementia, post-stroke dementia and 
post-stroke no dementia. Control samples were exam-
ined from old and young individuals devoid of brain 
pathology. All dementias showed higher vascular pa-
thology scores than corresponding age-matched con-
trols. In relation to these controls, white matter lesion 
scores were also higher in all dementias, with the high-
est values corresponding to vascular dementia and post-
stroke dementia. The two latter conditions showed the 
highest abundance of string vessels, which were ob-
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served to a lesser extent in the other dementia types. 
The density of COL4+ and GLUT1+ capillaries was lower in 
the white matter than in the cortex and was also lower 
in dementia patients versus aged controls, with the 
exception of individuals that had suffered a stroke. The 
capillary width in the white matter was 31% greater than 
in the cortex. Notably, white matter capillaries were 
wider in all dementias compared to all controls irrespec-
tive of age. Moreover, there was a moderate positive 
correlation between capillary width and white matter 
lesion scores. These results indicate adaptive compensa-
tory mechanisms for chronic hypoperfusion in aging-
related dementias. An emerging risk factor recently 
recognized as a driver of cerebral vascular dysfunction 
and hypoperfusion is high-salt intake (Faraco et al., 
2018). Interestingly, the underlying mechanism is not 
dependent on salt-induced hypertension but on a com-
plex innate immune response mediated by alterations in 
the gut immune system (Faraco et al., 2018). Last year, a 
study by the same team reported that chronic dietary 
high-salt intake in mice promotes cognitive impairment 
by inducing phosphorylation of the microtubule-
associated protein tau rather than by insufficient cere-
bral perfusion (Faraco et al., 2019). The presence of 
hyperphosphorylated tau is one of the hallmarks of Alz-
heimer’s disease that has also been reported in patients 
with vascular cognitive impairment. Mice exposed to 
high-salt diet for several months developed signs of 
cognitive impairment that correlated with the phos-
phorylation and aggregation of tau in the brain tissue. 
Through different experimental strategies, the study 
demonstrated that high-salt diet impaired the produc-
tion of endothelial nitric oxide following denitrosylation 
of calpain. Deficient nitric oxide generation activated 
cyclin-dependent kinase 5 (Cdk5) which caused tau 
phosphorylation. Although these important findings 
were obtained in mice with unrealistically high levels of 
salt intake, the study identifies a causal relation between 
high-salt intake, vascular dysfunction, tau pathology, and 
cognitive impairment independent of cerebral hy-
poperfusion. 
9. Critical role of pericytes in BBB 
function and more 
Pericytes are mural cells surrounding capillaries 
that play essential functions in development and 
maintenance of BBB integrity. Pericytes facilitate molec-
ular pathways critical in preventing vascular malfor-
mations, and it appears that these cells can generate 
factors that directly support neuronal viability. Recent 
studies have provided valuable information regarding 
the biology of pericytes as well as their role in vascular 
function. Using Pdgfrb-CreERT2 mice with Cre expression 
induced in mural cells by tamoxifen administration, 
Diéguez-Hurtado et al. (2019) deleted the expression of 
the Rbpj gene encoding a transcriptional regulator of the 
Notch signaling pathway. Ablation of Rbpj at early post-
natal stages caused brain hemorrhages, AVMs at the pial 
surface, endothelial cell hyperplasia and apoptosis, en-
largement of the subendothelial basement membrane, 
and reduced blood flow. These changes were accompa-
nied by astroglial and microglia reactions, inflammation, 
edema, and some neuronal loss around severely affect-
ed blood vessels. Rbpj deletion upregulated genes of the 
TGFß pathway. The study provides evidence showing 
that mice with Rbpj gene deficiency in mural cells devel-
oped signs of CCMs. Interestingly, when Rbpj was delet-
ed in mural cells of adult mice, the above phenotype was 
no longer observed. However, induction of permanent 
brain ischemia in these mice caused increased edema, 
larger brain lesion volumes, and exacerbated inflamma-
tion and vascular abnormalities. Beyond the critical role 
of pericytes in brain vascular function, Nikolakopoulou 
et al. (2019) elucidated the role of pericytes in neuronal 
survival under conditions of vascular dysfunction. A 
mouse pericyte inducible cre-line was generated using a 
double gene promoter strategy including both Pdgfrb 
and Cspg4 promoters to increase the specificity of Cre 
expression in pericytes over other cells. This line was 
crossed with mice expressing inducible human diphthe-
ria toxin receptor under control of an upstream loxP-
flanked STOP sequence. Injection of tamoxifen induced 
DTR expression in pericytes which then became suscep-
tible to diphtheria toxin. Ablation of pericytes in adult 
mice reduced tight junction proteins zonula occludens 
and occludin, reduced adherens junction VE-cadherin on 
cortical and hippocampal capillaries, decreased CBF, and 
increased BBB breakdown. Pericyte loss was followed by 
vasogenic edema, confirming the involvement of peri-
cytes in maintaining adult BBB function. Furthermore, 
neuron loss in the cortex and hippocampus as well as 
behavioral deficits were detected several days after 
pericyte ablation.  A brain-specific pericyte-secreted 
growth factor termed pleiotropin was hypothesized to 
prevent neuronal loss. In vitro, pleiotropin was able to 
protect neurons under hypoxic conditions. In vivo, si-
lencing pleiotropin expression was not sufficient to 
cause neuronal loss. However, ischemia or excitotoxic 
lesions in mice with silenced pleiotropin expression 
caused larger infarctions and more neuronal degenera-
tion. The study concluded that pericyte-dependent plei-
otropin-mediated neurotrophic support promotes neu-
ronal survival under circulatory stress. The expedient 
neuronal loss found in this model of pericyte ablation is 
intriguing because it was not found in previous pericyte-
deficient models. The findings could be relevant to other 
neurodegenerative conditions if the dependence of 
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neuronal survival on neurotrophic factors provided by 
pericytes under vascular stress is confirmed. 
10. Molecules derived from the vascu-
lar endothelium impact neuronal func-
tion 
In addition to pericytes, endothelial cells seem to 
signal to neurons. Tan et al. (2019) showed that the 
endothelium secretes semaphorin 3G (Sema3G) which 
regulates synaptic structure and plasticity in hippocam-
pal neurons through actions on the neuronal neuropilin-
2/PlexinA4 holoreceptor. This study suggests a direct link 
between endothelial-derived factors and neuronal func-
tion beyond the supply of oxygen and nutrients through 
blood flow and proposes a molecular mechanism by 
which endothelial dysfunction can alter neuronal circuits 
and cognition. The study shows that Sema3G increases 
excitatory synapse density via neuropilin-2/PlexinA4 
signaling and activation of Rac1. To determine whether 
Sema3G was derived from endothelial cells, mice bear-
ing a Sema3G deletion selectively in endothelial cells 
were obtained by crossing Cdh5-Cre mice with floxed 
Sema3G mice. These mice showed less dendritic spine 
density in the CA1 and impaired memory. Nonetheless, 
Sema3G deletion with this strategy would cause Sema3G 
deficiency during developmental stages which may 
cause indirect alterations and compensatory changes. 
Generation of tamoxifen inducible Cdh5-
creERT2/Sema3Gfl/fl mice allowed deleting Sema3G in the 
endothelium of adult mice. This inducible deletion signif-
icantly impaired hippocampal long-term potentiation 
frequency and altered miniature excitatory post-synaptic 
currents in CA1 pyramidal neurons. Furthermore, Se-
ma3G overexpression improved spine density loss and 
cognitive defects in Cdh5-creERT2/Sema3Gfl/fl mice. The 
results suggest that endothelium-derived Sema3G is 
required for normal hippocampal synaptic plasticity in 
adulthood. This study raises many questions regarding 
the mode of transit of Sema3G from the vascular endo-
thelium to the neurons through the vascular and astro-
cytic basal laminae and astrocytic end-feet, and whether 
the source of Sema3G is the capillary endothelium. The 
discovery of molecular interactions between endothelial 
cells and neurons suggest that endothelial cells influence 
neuronal function. Therefore, alterations in the vascular 
endothelium might exert a direct effect on dendritic 
spine function and contribute to cognitive decline and 
memory loss. Other recent studies further support the 
view that molecules generated by the cerebrovascular 
endothelium have a direct impact on neuronal function. 
Liu et al. (2020) showed that mice with a selective dele-
tion of Cdk5 gene show a higher endothelial chemokine 
Cxcl1 expression. Therefore, dysregulation of Cdk5 ex-
pression and/or function seems to be critical in different 
forms of cerebrovascular alterations. Endothelial Cdk5 
knockout mice showed astrogliosis in the hippocampus 
and weakened astrocytic glutamate current mediated by 
the astroglial glutamate transporter GLT1. The effects on 
astroglia were mediated by endothelial-derived Cxcl1 
acting on the astrocytic receptor Cxcr2. These altera-
tions had consequences for neurons since they reduced 
glutamate uptake and increased the excitability of hip-
pocampal pyramidal neurons causing seizures in mice 
with endothelial-deficient Cdk5. Although current evi-
dence is still scarce and based on experimental animal 
studies, the possibility that vascular endothelial cells 
generate molecules that signal to neurons and astro-
cytes and govern neuronal function warrants future 
studies. 
Conclusion 
The above studies discovered contributing factors 
to neurovascular pathology. Adequate CBF supply and 
BBB integrity require homeostasis in the cellular and 
extracellular environment around blood vessels. Moreo-
ver, the concept is emerging that pericytes and endothe-
lial cells can signal to neurons by releasing certain specif-
ic molecular cues. Ideally, the novel knowledge of genet-
ic risk factors, molecular mechanisms, cell and system 
interactions, as well as pathologic and imaging hallmarks 
in cerebrovascular diseases should translate into cura-
tive treatments that are currently unavailable. 
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